Capital Advisors Ltd’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-38
Closed 1378
2022
Q2
$0 Buy
+38
New ﹤0.01% 1172